Skip to main content

Ruxolitinib Cream for the Treatment of Discoid Lupus Erythematosus

Research Question:
Does Ruxolitinib treatment work for discoid lupus?

Basic Study Information

The purpose of this study is to assess the potential beneficial effect of ruxolitinib cream for the treatment of discoid lupus erythematosus. There are no creams specifically FDA-approved for use in lupus and a great need exists for new treatments. Ruxolitinib cream has been shown to be safe and effective in a number of other skin diseases such as eczema, but has not been studied in discoid lupus. You are eligible if you are 18 years old or older, have a diagnosis of discoid lupus, and have at least one active lesion on your skin.

Location: University of Rochester Medical Center
Study Reference #: STUDY00006186

Lead Researcher (Principal Investigator)

Lead Researcher:  Christopher Richardson

Study Contact Information

Study Coordinator: Michelle G. Smith
Phone: (585) 275-0374

Additional Study Details

Study Details:
If you decide to take part in this study, you will be asked to apply ruxolitinib cream to your lupus skin lesions twice a day for 12 weeks. You will also be asked to visit the clinic a total of seven times for assessment of your treatment.

Number of Visits:  6 to 10
Reimbursement:  Yes

Contact This Study

This field is required
This field is required
You must agree to be contacted to continue.

Return to Search